Regenxbio stock gains on positive gene therapy trial data
Go back to Regenxbio stock gains on positive gene therapy trial data| Jennison Natural Resources Fund Class B (NASDAQ: RGNX) | Delayed: 7.40 +0.16 (2.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.24 | 52 Week High | $25.00 | |||
| Open | $7.53 | 52 Week Low | $7.07 | |||
| Day High | $7.68 | P/E | N/A | |||
| Day Low | $7.17 | EPS | $0.00 | |||
| Volume | 1,276,450 | |||||
